• 1. An integrated system for field analysis of Cd(ii) and Pb(ii) via preconcentration using nano-TiO2/cellulose paper composite and subsequent detection with a portable X-ray fluorescence spectrometer?
  Xiaofeng Lin RSC Adv., 2016,6, 9002-9006
• 2. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 3. An amorphous lanthanum–iridium solid solution with an open structure for efficient water splitting?
  Wei Sun,Chenglong Ma,Xinlong Tian,Jianjun Liao,Ji Yang,Chengjun Ge,Weiwei Huang J. Mater. Chem. A, 2020,8, 12518-12525
• 4. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 5. An Assessment of the Laminar Hypersonic Double-Cone Experiments in the LENS-XX Tunnel
  JaideepRay,PatrickBlonigan,EricT.Phipps,KathrynMaupin

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Acids/Esters

L-Phenylalanine amide hydrochloride (CAS No. 65864-22-4): A Comprehensive Overview in Modern Chemical and Pharmaceutical Research

L-Phenylalanine amide hydrochloride, identified by the Chemical Abstracts Service Number (CAS No.) 65864-22-4, is a compound of significant interest in the realms of chemical biology and pharmaceutical innovation. This amide derivative of L-phenylalanine, when combined with hydrochloride salt form, exhibits unique biochemical properties that make it a valuable candidate for various research applications. The compound's molecular structure, characterized by its amino and carboxyl functional groups, contributes to its versatility in molecular interactions, making it a focal point in contemporary studies aimed at unraveling the complexities of protein-protein interactions and enzyme mechanisms.

The significance of L-Phenylalanine amide hydrochloride is further underscored by its role in the development of novel therapeutic agents. In recent years, there has been a surge in research focusing on the synthesis and characterization of peptidomimetics—molecules designed to mimic the bioactivity of natural peptides but with enhanced stability and pharmacological profiles. The incorporation of amide linkages into drug candidates has been shown to improve metabolic resistance, solubility, and overall bioavailability. L-Phenylalanine amide hydrochloride serves as an exemplary structure in this context, providing a scaffold for designing molecules that can interact with biological targets with high specificity.

One of the most compelling aspects of L-Phenylalanine amide hydrochloride is its potential application in the field of neuroscience. Phenylalanine derivatives have long been studied for their effects on neurotransmitter systems, particularly those involving dopamine and serotonin. The amide moiety in L-Phenylalanine amide hydrochloride can modulate the activity of enzymes such as monoamine oxidase (MAO), which are crucial in regulating neurotransmitter levels. Recent studies have highlighted the compound's ability to act as a selective MAO inhibitor, a property that could be exploited in the treatment of neurodegenerative disorders such as Parkinson's disease. The hydrochloride salt form enhances the compound's solubility, facilitating its use in both in vitro and in vivo experimental models.

In addition to its neuropharmacological applications, L-Phenylalanine amide hydrochloride has shown promise in oncology research. The ability of peptidomimetics to disrupt protein-protein interactions has led to their exploration as inhibitors of key oncogenic pathways. For instance, studies have demonstrated that derivatives of phenylalanine can interfere with the activity of tyrosine kinases, which are often overexpressed in cancer cells. The structural features of L-Phenylalanine amide hydrochloride, including its aromatic ring and amide bond, allow it to bind to target proteins with high affinity. This binding capability makes it a valuable tool for developing targeted therapies that can selectively inhibit cancer cell proliferation without affecting normal cells.

The synthesis of L-Phenylalanine amide hydrochloride is another area where advancements have been made. Modern synthetic methodologies have enabled researchers to produce this compound with high purity and yield, making it more accessible for diverse applications. Techniques such as solid-phase peptide synthesis (SPPS) have been particularly useful in constructing complex peptidomimetics like L-Phenylalanine amide hydrochloride. These methods allow for precise control over the molecular structure, enabling the introduction of various modifications that can enhance pharmacological properties. The development of efficient synthetic routes has not only facilitated research but also paved the way for large-scale production, which is essential for clinical trials and commercialization.

The analytical characterization of L-Phenylalanine amide hydrochloride is equally important. Advanced spectroscopic techniques such as nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry (MS), and X-ray crystallography have provided detailed insights into its structural properties. NMR spectroscopy allows for the elucidation of atomic connectivity and dynamics, while MS provides information on molecular weight and fragmentation patterns. X-ray crystallography offers high-resolution structures of the compound, revealing how it interacts with biological targets at an atomic level. These analytical tools are indispensable for understanding the mechanism of action of L-Phenylalanine amide hydrochloride and optimizing its pharmacological efficacy.

In conclusion, L-Phenylalanine amide hydrochloride (CAS No. 65864-22-4) represents a significant advancement in chemical biology and pharmaceutical research. Its unique structural features make it a versatile molecule with applications spanning neuroscience, oncology, and beyond. The ongoing research into peptidomimetics like this compound underscores their potential as next-generation therapeutic agents. As synthetic methodologies continue to evolve and analytical techniques become more sophisticated, we can expect even greater insights into the biochemical roles and therapeutic possibilities of L-Phenylalanine amide hydrochloride. This compound exemplifies how targeted molecular design can lead to innovative solutions in medicine and biotechnology.

• 5241-58-7((2S)-2-Amino-3-phenylpropionyl Amide)
• 53559-18-5(H-Tyr-NH2 Hydrochloride)
• 108321-83-1(DL-Phenylalanine amide hydrochloride)
• 17193-31-6(2-Amino-3-Phenylpropanamide)
• 71666-94-9(H-D-PHE-NH2 Hydrochloride)
• 138228-64-5((R)-2-amino-4-phenyl-butyricacidamide;hydrochloride)
• 5241-59-8((2R)-2-amino-3-phenylpropanamide)
• 117888-79-6(H-D-Tyr-NH2 Hydrochloride)
• 1236261-00-9(2-Amino-N-methyl-3-phenylpropanamide hydrochloride)
• 60058-39-1(Benzenepropanamide, a-amino-)